Considerations for Unblinding in Biopharmaceutical Industry Sponsored Trials

&
American Journal of Bioethics 18 (10):68-70 (2018)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2018.1513588

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,349

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Industry-Corrupted Psychiatric Trials.Leemon McHenry, Jon Jureidini & Jay Amsterdam - 2017 - Psychiatria Polska 51 (6):993-1008.
Shortcomings of protocols of drug trials in relation to sponsorship as identified by Research Ethics Committees: analysis of comments raised during ethical review.Marlies van Lent, Gerard A. Rongen & Henk J. Out - 2014 - BMC Medical Ethics 15 (1):83.
Better Regulation of Industry-Sponsored Clinical Trials is Long Overdue.Matthew Wynia & David Boren - 2009 - Journal of Law, Medicine and Ethics 37 (3):410-419.
More Regulation of Industry-Supported Biomedical Research: Are We Asking the Right Questions?Sigrid Fry-Revere & David Bjorn Malmstrom - 2009 - Journal of Law, Medicine and Ethics 37 (3):420-430.
On the Proposed Changes to the Credibility Gap in Industry-Supported Biomedical Research: A Critical Evaluation.Leemon McHenry & Jon Jureidini - 2012 - Ethical Human Psychology and Psychiatry 14 (3):156-161.
The Paroxetine 352 Bipolar Trial: A Study in Medical Ghostwriting.Leemon McHenry & Jay Amsterdam - 2012 - International Journal of Risk and Safety in Medicine 24 (4):221-231.
How Clinical Trials Really Work Rethinking Research Ethics.Debra A. DeBruin, Joan Liaschenko & Anastasia Fisher - 2011 - Kennedy Institute of Ethics Journal 21 (2):121-139.
Why Most Sugar Pills Are Not Placebos.Bennett Holman - 2015 - Philosophy of Science 82 (5):1330-1343.
Ethical Considerations for Unblinding a Participant’s Assignment to Interpret a Resolved Adverse Event.Benjamin S. Wilfond, Christian Morales, Liza-Marie Johnson & Holly A. Taylor - 2018 - American Journal of Bioethics 18 (10):66-67.
Strategic Corporate Social Responsibility and Orphan Drug Development: Insights from the US and the EU Biopharmaceutical Industry. [REVIEW]Olga Bruyaka, Hanko K. Zeitzmann, Isabelle Chalamon, Richard E. Wokutch & Pooja Thakur - 2013 - Journal of Business Ethics 117 (1):45-65.
Clinical Trials and Drug Promotion.Jon Jureidini, Leemon McHenry & Peter Mansfield - 2008 - International Journal of Risk and Safety in Medicine 20:73-81.
The definition of adequate care in externally sponsored clinical trials: The terminological controversy about the concept “standard of care”.Hans-Jörg Ehni - 2006 - Science and Engineering Ethics 12 (1):123-130.
Better Regulation of Industry-Sponsored Clinical Trials Is Long Overdue.Matthew Wynia & David Boren - 2009 - Journal of Law, Medicine and Ethics 37 (3):410-419.
Frustration considerations of the small-trials partial reinforcement effect: Experience with nonreward and intertrial reinforcement.Charles I. Brooks - 1971 - Journal of Experimental Psychology 89 (2):362.
Ethical Considerations for Volunteer Recruitment of Visual Prosthesis Trials.Yu Xia & Qiushi Ren - 2013 - Science and Engineering Ethics 19 (3):1099-1106.

Analytics

Added to PP
2018-10-21

Downloads
9 (#1,219,856)

6 months
4 (#818,853)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references